Partnership expands depth and breadth of clinical services
Wayne, Pa. – January 30, 2006 – Octagon Research Solutions, the leader in the electronic transformation of clinical R&D, today announced a new partnership with DSP Clinical Research (DSP). The partnership is aimed at leveraging the unique expertise of both organizations to offer a greater depth of knowledge and experience across an expanded collection of service offerings.
DSP Clinical Research brings a wealth of knowledge and experience in clinical trial management including investigator site management, study management and site monitoring. Octagon has significant domain expertise in clinical data strategy and management as well as the regulatory aspects of clinical drug development. The expertise presented by each partner offers a seamless approach to clients who are committed to strategic outsourcing. By connecting trial management activities to data and eventually submission management activities, greater efficiencies can be realized.
"The partnership developed as a natural extension of our project work experiences," noted Jim Walker, president and CEO of Octagon. "We have worked with DSP on several projects and found that their expertise complements our internal skill sets and enables us to jointly bring greater value to our clients. The partnership formalizes what is already a great relationship between two innovative organizations."
Darlene Panzitta, president and founder of DSP added, "DSP has extensive experience across multiple therapeutic areas in Phase I-IV clinical studies. Our partnership with Octagon allows us to broaden our services while continuing to focus on our core strengths. We are pleased to be working with an organization that approaches client engagements with the same energy, enthusiasm and level of expertise that we bring to our projects."
About Octagon Research Solutions, Inc.
Octagon is a leading process-centric solutions provider that offers a suite of regulatory, clinical, process and IT solutions to the life sciences industry. Octagon synchronizes processes and increases automation to reduce island-to-island inefficiencies within the clinical research and development process. We leverage the power of electronic submissions through cross-functional eSub expertise, a holistic process approach, deep domain knowledge and integrated solutions. Octagon is headquartered in Wayne, PA, with offices in Boston, MA, Costa Mesa, CA, and European headquarters in Amersham, UK. For more information please visit www.octagonresearch.com .
About DSP Clinical Research
DSP Clinical Research is a trial management organization whose main objective is to successfully manage clinical trials by focusing on 3 key elements: investigator site management, study management and site monitoring. DSP Clinical Research can set up and manage Phase I-IV clinical trials from study set up through NDA submission, as well as offer customized services. The company is headquartered in Fairfield, NJ, with offices in Miami, FL. For more information please visit www.dspclinical.com .
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.